ADRAFINIL - EFFECT, APPLICATION & RISKS - ACTIVE INGREDIENTS

Adrafinil



Editor'S Choice
Inhibitory postsynaptic potential
Inhibitory postsynaptic potential
The drug Adrafinil was launched in 1985 by the pharmaceutical company Cephalon. The drug treats narcolepsy and sleep disorders associated with narcolepsy.